Skip to main content
. 2012 Aug 27;39(3):692–702. doi: 10.1093/schbul/sbs077

Fig. 3.

Fig. 3.

Continuous haloperidol (0.5mg/kg/day via minipump; CONT-HAL), but not continuous olanzapine (10mg/kg/day via minipump; CONT-OLZ) or intermittent olanzapine (1mg/kg/day via subcutaneous [SC] injection; INT-OLZ) treatment enhanced amphetamine-induced locomotion. n′s = 14/condition. *P < .05 compared with vehicle (VEH). Data are means ± SEM. VEH, group injected daily with SC phosphate-buffered saline. AMPH, amphetamine.